Abacoa & Alton Neighbors - November 2025

10 A B A C O A & A LT O N N E I G H B O R S | N O V E M B E R 2 0 2 5 Lung cancer is the leading cause of cancer death among both men and women in the United States, according to the Centers for Disease Control and Prevention. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined, according to the American Cancer Society® (ACS). Wellington Regional Medical Center has acquired the Ion® Robotic Bronchoscopy System, developed by Intuitive, creators of the da Vinci® robotic surgical system, which helps detect and address lung nodules in their early stages. Q: What is the benefit of the Ion Robotic Bronchoscopy System? A: The system is a robotic-assisted technology that enables doctors to diagnose and treat lung cancer at earlier stages than previously possible. They can perform complex procedures with more precision, flexibility, and control than with conventional surgical techniques. Q: How does the system work? A: During bronchoscopy with Ion, the physician uses the controller to navigate to the target along a planned path. The catheter can articulate 180° in any direction to pass through small, difficult-to- navigate airways and around tight bends to reach all segments of the lung. The enhanced capabilities enable physicians to get to nodules deep in the lung with less difficulty. Q: Is it less risky than a standard CT-guided bronchoscopy procedure? A: This new technology can result in reduced or avoided complications of more invasive approaches to biopsy, such as collapsed lung or pneumothorax, improve patient outcomes, and provide an enhanced patient pathway for therapy. Q: Who should get a lung screening? A: The American Cancer Society recommends yearly screening for lung cancer with a low-dose CT (LDCT) scan for people aged 50 BUSINESS PROFILE A MINIMALLY INVASIVE OPTION FOR - Submitted by Kyle Tassone - Lung Biopsies